EHRA Premium Access

Anticoagulation for non-valvular atrial fibrillation in 2017

Event: EHRA EUROPACE - CARDIOSTIM 2017
Topic: Anticoagulation
Session type: Symposium
Date: 20 June 2017
Time: 08:30 - 10:00

Session

4 presentations in this session

What is the correct definition of “non-valvular” atrial fibrillation?

Speaker: Associate Professor T. Potpara (Belgrade, RS)
Thumbnail

Permanent atrial fibrillation with CHADS-VASC score= 1: nothing, aspirin or anticoagulate?

Speaker: Associate Professor A. Niessner (Vienna, AT)
Thumbnail

Anticoagulant should be prescribed for Atrial fibrillation in stage IV-V kidney disease.

Speaker: Associate Professor M. Chelu (Houston, US)
Thumbnail

Anticoagulant should NOT be prescribed for Atrial fibrillation in stage IV-V kidney disease.

Speaker: Doctor A. Natale (Austin, US)
Thumbnail

4 speakers from this session

Associate Professor Tatjana Potpara

Belgrade University School of Medicine, Belgrade (Serbia)
32 presentations
1 follower

Associate Professor Alexander Niessner

Medical University of Vienna, Vienna (Austria)
6 presentations
0 follower

Associate Professor Mihail Chelu

Baylor College of Medicine, Houston (United States of America)
3 presentations
0 follower

Doctor Andrea Natale

St. David's Medical Center, Austin (United States of America)
2 presentations
0 follower

This platform is supported by

logo Novo Nordisk